Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Erratum: Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: The impact of body weight and target on an optimal dosing regimen (Journal of Antimicrobial Chemotherapy (2019) 74 (2984-2993) DOI: 10.1093/jac/dkz270)

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{dde08a7321844d0d94e31a690bf933b8,
title = "Erratum: Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: The impact of body weight and target on an optimal dosing regimen (Journal of Antimicrobial Chemotherapy (2019) 74 (2984-2993) DOI: 10.1093/jac/dkz270)",
abstract = "Some errors were present in the original published version of this article. First, in the Results, Target attainment section, the sentence 'For the licensed dosing regimen, target achievement requires doses from0.67-1.96 and 2.10-9.25 times the standard 80 mg/kg (50% fT>4%MIC and 100% fT>1%MIC, respectively).' should have read 'For the licensed dosing regimen, target achievement requires doses from0.67-1.96 and 1.98-5.78 times the standard 80 mg/kg (50%fT>4%MIC and 100%fT>1%MIC, respectively).' Second, in Figure 5, some of the values for dose and AUCss were incorrect. The corrected figure is given below. (Figure presented). The errors have now been corrected in the online version of the article. The authors and Journal apologize for these errors.",
author = "Anders Thorsted and Kristoffersson, {Anders N} and Maarbjerg, {Sabine F} and Henrik Schr{\o}der and Mikala Wang and Birgitte Brock and Nielsen, {Elisabet I} and Friberg, {Lena E}",
year = "2020",
month = jan,
day = "1",
doi = "10.1093/jac/dkz429",
language = "English",
volume = "75",
pages = "254--255",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "1",

}

RIS

TY - JOUR

T1 - Erratum

T2 - Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: The impact of body weight and target on an optimal dosing regimen (Journal of Antimicrobial Chemotherapy (2019) 74 (2984-2993) DOI: 10.1093/jac/dkz270)

AU - Thorsted, Anders

AU - Kristoffersson, Anders N

AU - Maarbjerg, Sabine F

AU - Schrøder, Henrik

AU - Wang, Mikala

AU - Brock, Birgitte

AU - Nielsen, Elisabet I

AU - Friberg, Lena E

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Some errors were present in the original published version of this article. First, in the Results, Target attainment section, the sentence 'For the licensed dosing regimen, target achievement requires doses from0.67-1.96 and 2.10-9.25 times the standard 80 mg/kg (50% fT>4%MIC and 100% fT>1%MIC, respectively).' should have read 'For the licensed dosing regimen, target achievement requires doses from0.67-1.96 and 1.98-5.78 times the standard 80 mg/kg (50%fT>4%MIC and 100%fT>1%MIC, respectively).' Second, in Figure 5, some of the values for dose and AUCss were incorrect. The corrected figure is given below. (Figure presented). The errors have now been corrected in the online version of the article. The authors and Journal apologize for these errors.

AB - Some errors were present in the original published version of this article. First, in the Results, Target attainment section, the sentence 'For the licensed dosing regimen, target achievement requires doses from0.67-1.96 and 2.10-9.25 times the standard 80 mg/kg (50% fT>4%MIC and 100% fT>1%MIC, respectively).' should have read 'For the licensed dosing regimen, target achievement requires doses from0.67-1.96 and 1.98-5.78 times the standard 80 mg/kg (50%fT>4%MIC and 100%fT>1%MIC, respectively).' Second, in Figure 5, some of the values for dose and AUCss were incorrect. The corrected figure is given below. (Figure presented). The errors have now been corrected in the online version of the article. The authors and Journal apologize for these errors.

UR - http://www.scopus.com/inward/record.url?scp=85076447418&partnerID=8YFLogxK

U2 - 10.1093/jac/dkz429

DO - 10.1093/jac/dkz429

M3 - Comment/debate

C2 - 31650174

VL - 75

SP - 254

EP - 255

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 1

ER -

ID: 61318568